Evidence map›Paper›PMID 27344019›Full record

ArticleJournal of neurochemistry2016

Functional interaction between Lypd6 and nicotinic acetylcholine receptors.

Maria Arvaniti, Majbrit M Jensen, Neeraj Soni, Hong Wang, Anders B Klein, Nathalie Thiriet, Lars H Pinborg, Pretal P Muldoon, Jacob Wienecke, M Imad Damaj and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. HumanOncotarget · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Evolution and Medical Significance of LU Domain-Containing Proteins.International journal of molecular sciences · 2019
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Maria ArvanitiDepartment of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Majbrit M JensenNeurobiology Research Unit, University Hospital Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Neeraj SoniDepartment of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Hong WangLaboratory for Neurodevelopment, Department of Anatomy, Howard University College of Medicine, Washington, District of Columbia, USA.
Anders B KleinDepartment of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Nathalie ThirietLaboratory of Experimental and Clinical Neurosciences, University of Poitiers, Poitiers, France.
Lars H PinborgNeurobiology Research Unit, University Hospital Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Pretal P MuldoonDepartment of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA.
Jacob WieneckeDepartment of Nutrition, Exercise and Sport & Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
M Imad DamajDepartment of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA.
Kristi A KohlmeierDepartment of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Marjorie C Gondré-LewisLaboratory for Neurodevelopment, Department of Anatomy, Howard University College of Medicine, Washington, District of Columbia, USA.
Jens D MikkelsenNeurobiology Research Unit, University Hospital Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Morten S ThomsenDepartment of Drug Design & Pharmacology, University of Copenhagen, Copenhagen, Denmark. morten.s.thomsen@sund.ku.dk.
University of Copenhagen · DKCopenhagen University Hospital · DKHoward University · USVirginia Commonwealth University Medical Center · USRigshospitalet · DKUniversité de Poitiers · FR

Funding

Research_ProjectU54HD090257 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P. · 2016 to 2020
$5.9M
Excessive Alcohol Drinking Associated with GABA Alpha 2-Regulated TLR4 ExpressionR01AA021262 · NIAAA · HOWARD UNIVERSITY · PI AURELIAN, LAURE, GONDRE-LEWIS, MARJORIE C · 2013 to 2017
$2.3M
Genes and molecular pathways in nicotine dependence and withdrawalR01DA032246 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, MILES, MICHAEL F · 2013 to 2017
$1.7M
Role of calcium-dependent mechanisms in nicotine's tolerance and effectsR01DA012610 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD · 2001 to 2010
$1.6M
A Role for Glycosphingolipids in Regulatory Mechanisms of Neuron DevelopmentSC2NS065385 · NINDS · HOWARD UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C · 2008 to 2010
$507k
NIAAA NIH HHS R01 AA021262NICHD NIH HHS U54 HD090257NIDA NIH HHS R01 DA012610NIDA NIH HHS R01 DA032246NINDS NIH HHS SC2 NS065385
6 · The paper itself

Abstract

Nicotinic acetylcholine receptors (nAChRs) affect multiple physiological functions in the brain and their functions are modulated by regulatory proteins of the Lynx family. Here, we report for the first time a direct interaction of the Lynx protein LY6/PLAUR domain-containing 6 (Lypd6) with nAChRs in human brain extracts, identifying Lypd6 as a novel regulator of nAChR function. Using protein cross-linking and affinity purification from human temporal cortical extracts, we demonstrate that Lypd6 is a synaptically enriched membrane-bound protein that binds to multiple nAChR subtypes in the human brain. Additionally, soluble recombinant Lypd6 protein attenuates nicotine-induced hippocampal inward currents in rat brain slices and decreases nicotine-induced extracellular signal-regulated kinase phosphorylation in PC12 cells, suggesting that binding of Lypd6 is sufficient to inhibit nAChR-mediated intracellular signaling. We further show that perinatal nicotine exposure in rats (4 mg/kg/day through minipumps to dams from embryonic day 7 to post-natal day 21) significantly increases Lypd6 protein levels in the hippocampus in adulthood, which did not occur after exposure to nicotine in adulthood only. Our findings suggest that Lypd6 is a versatile inhibitor of cholinergic signaling in the brain, and that Lypd6 is dysregulated by nicotine exposure during early development. Regulatory proteins of the Lynx family modulate the function of nicotinic receptors (nAChRs). We report for the first time that the Lynx protein Lypd6 binds to nAChRs in human brain extracts, and that recombinant Lypd6 decreases nicotine-induced ERK phosphorylation and attenuates nicotine-induced hippocampal inward currents. Our findings suggest that Lypd6 is a versatile inhibitor of cholinergic signaling in the brain.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAnimals, NewbornAntigens, LyBrain ChemistryGPI-Linked ProteinsHumansIn Vitro TechniquesMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutNicotineNicotinic AgonistsPC12 CellsAdaptor Proteins, Signal TransducingAntigens, LyGPI-Linked ProteinsLYPD6 protein, humanNicotineNicotinic AgonistsReceptors, Nicotinicaffinity purificationLy-6LY6/PLAUR domain-containing 6Lynxnicotine

Identifiers

PMID27344019
PMCPMC5017906
OpenAlexW2468467022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.